Dawn Carter Bir - Mar 6, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Chief Commercial Officer
Signature
/s/ Tracy Herson, attorney-in-fact
Stock symbol
RETA
Transactions as of
Mar 6, 2023
Transactions value $
-$6,609,121
Form type
4
Date filed
3/8/2023, 04:17 PM
Previous filing
Mar 6, 2023
Next filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Conversion of derivative security +48.4K +99.71% 96.9K Mar 6, 2023 Direct F1
transaction RETA Class A common stock Sale -$3.58M -40.1K -41.43% $89.30 56.7K Mar 6, 2023 Direct F2
transaction RETA Class A common stock Sale -$1.34M -14.8K -26.12% $90.26 41.9K Mar 6, 2023 Direct F3
transaction RETA Class A common stock Conversion of derivative security +41.6K +99.3% 83.6K Mar 7, 2023 Direct F1
transaction RETA Class A common stock Sale -$3.07M -36K -43.14% $85.08 47.5K Mar 7, 2023 Direct F4
transaction RETA Class A common stock Sale -$498K -5.79K -12.19% $85.90 41.7K Mar 7, 2023 Direct F5
transaction RETA Class A common stock Sale -$17.3K -200 -0.48% $86.67 41.5K Mar 7, 2023 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Employee Stock Option (right to buy) Options Exercise $0 -48.4K -53.74% $0.00 41.6K Mar 6, 2023 Class B common stock 48.4K $21.05 Direct F1, F7
transaction RETA Class B common stock Options Exercise $1.02M +48.4K $21.05 48.4K Mar 6, 2023 Class A common stock 48.4K Direct F1
transaction RETA Class B common stock Conversion of derivative security -48.4K -100% 0 Mar 6, 2023 Class A common stock 48.4K Direct F1
transaction RETA Employee Stock Option (right to buy) Options Exercise $0 -41.6K -100% $0.00* 0 Mar 7, 2023 Class B common stock 41.6K $21.05 Direct F1, F7
transaction RETA Class B common stock Options Exercise $876K +41.6K $21.05 41.6K Mar 7, 2023 Class A common stock 41.6K Direct F1
transaction RETA Class B common stock Conversion of derivative security -41.6K -100% 0 Mar 7, 2023 Class A common stock 41.6K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $88.90 to $89.88. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $89.91 to $90.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.58 to $85.56. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.63 to $86.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $88.635 to $86.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F7 The option vested 37,500 shares on September 6, 2017 and in twelve equal quarterly installments thereafter.